Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia

NCT00179231 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00179231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00179231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
Lead sponsor
Vanderbilt University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2000
Completion date
February 29, 2004
Enrollment
80
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia